|
Efficacy of treatment |
||||
| Effectiveness within 24 hoursa |
Complete remission in days |
Mortality |
||
|
|
||||
| Yes |
No |
|||
|
|
||||
| Dantrolene monotherapy |
23 (76.7%) |
7 (23.3%) |
9.4 (SD 12.7) |
6/37 (16.2%) |
| Dantrolene with additive medication |
30 (44.1%) |
38 (55.9%) |
19.0 (SD 31.6) |
6/82 (7.3%) |
| Other medication |
44 (67.7%) |
21 (32.3%) |
9.5 (SD 9.8) |
9/101 (8.9%) |
| Only supportive therapy |
9 (37.5%) |
15 (62.5%) |
9.2 (SD 18.4) |
1/51 (2.0%) |
|
aMissing values are due to the lack of detailed information in the reports. SD, standard deviation. | ||||
Reulbach et al. Critical Care 2007 11:R4 doi:10.1186/cc5148 |
||||